WASHINGTON -- The U.S. Department of Commerce today imposed a $35,000 civil penalty on Alaris Medical Systems, Inc., formerly IMED Corporation, of San Diego, Calif., to settle 16 alleged violations of the antiboycott provisions of the Export Administration Regulations, Commerce Assistant Secretary for Export Enforcement, F. Amanda DeBusk, announced. Alaris Medical Systems, Inc., manufactures medical devices.
The Department alleged that on ten occasions, between 1993 and 1995, IMED failed to report that it received requests from Kuwait to participate in the boycott of Israel. The Department also alleged that IMED, in six of those transactions, failed to maintain records containing information relating to reportable boycott requests, as required by the Regulations.
While neither admitting nor denying the allegations, Alaris agreed to pay the civil penalty.
The antiboycott provisions prohibit U.S. companies and individuals from complying with certain aspects of unsanctioned foreign boycotts against any country friendly to the United States that is not itself the object of any U.S. boycotts. Through its Office of Antiboycott Compliance, the Commerce Department investigates alleged violations, provides support in administrative or criminal litigation of cases, and prepares cases for settlement.
In April of 2002 the Bureau of Export Administration (BXA) changed its name to the Bureau of Industry and Security(BIS). For historical purposes we have not changed the references to BXA in the legacy documents found in the Archived Press and Public Information.